Patents by Inventor Tony SangYoung BYUN

Tony SangYoung BYUN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11851482
    Abstract: The present disclosure provides anti-complement factor Bb antibodies, and compositions comprising the antibodies. The anti-Bb antibodies are useful for treating complement-mediated disorders. The present disclosure provides methods of treating complement-mediated disorders.
    Type: Grant
    Filed: January 19, 2021
    Date of Patent: December 26, 2023
    Assignee: Genzyme Corporation
    Inventors: Sandip Panicker, Graham Parry, Karen Sue Christopherson, Tony SangYoung Byun
  • Publication number: 20210221877
    Abstract: The present disclosure provides anti-complement factor Bb antibodies, and compositions comprising the antibodies. The anti-Bb antibodies are useful for treating complement-me-diated disorders. The present disclosure provides methods of treating complement-mediated disorders.
    Type: Application
    Filed: January 19, 2021
    Publication date: July 22, 2021
    Inventors: Sandip Panicker, Graham Parry, Karen Sue Christopherson, Tony SangYoung Byun
  • Patent number: 10934347
    Abstract: The present disclosure provides anti-complement factor Bb antibodies, and compositions comprising the antibodies. The anti-Bb antibodies are useful for treating complement-mediated disorders. The present disclosure provides methods of treating complement-mediated disorders.
    Type: Grant
    Filed: April 3, 2017
    Date of Patent: March 2, 2021
    Assignee: Genzyme Corporation
    Inventors: Sandip Panicker, Graham Parry, Karen Sue Christopherson, Tony SangYoung Byun
  • Patent number: 10400018
    Abstract: Isolated tau peptides, and compositions comprising the peptides are disclosed. Further provided are antibodies specific for an isolated tau peptide. Methods of using the isolated tau peptide in diagnostic and treatment including using a pharmaceutical composition comprising the isolated tau peptide for stimulating an immune response in an individual to a tau peptide, and methods of using antibodies in detection, diagnosis, and treatment of disorders including a tauopathy are further provided.
    Type: Grant
    Filed: February 14, 2014
    Date of Patent: September 3, 2019
    Assignee: iPierian, Inc.
    Inventors: Irene Griswold-Prenner, Graham Parry, Tony SangYoung Byun
  • Publication number: 20190153079
    Abstract: The present disclosure provides anti-complement factor Bb antibodies, and compositions comprising the antibodies. The anti-Bb antibodies are useful for treating complement-mediated disorders. The present disclosure provides methods of treating complement-mediated disorders.
    Type: Application
    Filed: April 3, 2017
    Publication date: May 23, 2019
    Applicant: Bioverativ USA Inc.
    Inventors: Sandip Panicker, Graham Parry, Karen Sue Christopherson, Tony SangYoung Byun
  • Publication number: 20160347804
    Abstract: Isolated tau peptides, and compositions comprising the peptides are disclosed. Further provided are antibodies specific for an isolated tau peptide. Methods of using the isolated tau peptide in diagnostic and treatment including using a pharmaceutical composition comprising the isolated tau peptide for stimulating an immune response in an individual to a tau peptide, and methods of using antibodies in detection, diagnosis, and treatment of disorders including a tauopathy are further provided.
    Type: Application
    Filed: February 14, 2014
    Publication date: December 1, 2016
    Inventors: Irene GRISWOLD-PRENNER, Graham PARRY, Tony SangYoung BYUN